Title: COVID and Ketamine

Citations:

  • Pan K-Y, Kok AA, Eikelenboom M, Horsfall M, Jörg F, Luteijn RA, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry 2021. Available from: https://doi.org/10.1016/S2215-0366(20)30491-0.
  • Aguilar-Valles, A., De Gregorio, D., Matta-Camacho, E. et al. Antidepressant actions of ketamine engage cell-specific translation via eIF4E. Nature (2020). https://doi.org/10.1038/s41586-020-03047-0

Kaleidoscope team:

  • Dr Dawn N. Albertson

    Summarising Dawn’s academic trajectory is not easy but, roughly: behaviour, drugs, brains on drugs and then educating people about brains, behaviour, and drugs.

    View profile
  • Prof Sukhi S. Shergill

    A multilingual MD/PhD, Sukhi is a Professor of Psychiatry and Systems Neuroscience at the Institute of Psychiatry, Psychology, and Neuroscience at King’s College London and a Psychiatrist

    View profile
  • Dr Derek K. Tracy

    Derek is the Medical Director of West London NHS Trust, and a senior lecturer and King's College London and University College London.

    View profile
  • Dr Dan W. Joyce

    Certified genius and MD/PhD wunderkid, Dan works at the Department of Psychiatry, University of Oxford and is a Consultant Psychiatrist with Oxford Health NHS Foundation Trust. Veggie, data head, and a research purist, Dan’s signature acerbic wit brings comedy and clarity to all things complicated.

    View profile